Content area
Exegenesis Bio Inc - Pharmaceuticals and Healthcare Product Pipeline
Summary
Exegenesis Bio Inc (Exegenesis Bio) discovers and develops genetic medicines for eye, central nervous system (CNS) and liver-directed diseases. The company is investigating drugs for the treatment of spinal muscular atrophy, Parkinson’s disease, age related macular degeneration, Bietti’s crystalline dystrophy, hemophilia A, and phenylketonuria.
This report provides outline on pipeline products by Number of Pipeline Products by Therapy Area, Indication, development stage and Partnered/Out-Licensed Products.
This report is built using information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.